ATO can induce tumor cell differentiation, promote degradation of PML/RARα fusion protein, block specific intracellular signaling pathways, and trigger apoptosis by activating the intracellular caspase cascade, downregulating Bcl-2 expression and inhibiting NF-kB. Here, BCL2 is linked to neoplasm.